Therapeutic peptides and uses thereof
OwnerSiobhan Ellisoninventor
Life of this patent
Estimating the term…
Loading patent…
OwnerSiobhan Ellisoninventor
Estimating the term…
Methods for ameliorating neurodegenerative disorders and methods for ameliorating inflammatory disorders comprising administering to said subject an effective amount of a polypeptide comprising, in order from N-terminus to C-terminus, R-X1-X2-X3-X4-X5-R′ wherein: R is optionally 1-5 additional α-amino acids of either L-configuration or D configuration; X1 is any amino acid of either L-configuration or D-configuration; X2 is any amino acid of either L-configuration or D-configuration; X3 is Asp or Glu of either L-configuration or D-configuration; X4 is any amino acid of either L-configuration or D-configuration; X5 is any amino acid of either L-configuration or D-configuration; and R′ is optionally 1-5 additional α-amino acids of either L-configuration or D-configuration, with the proviso that at least three of X1, X2, X3, X4, and X5 are of the D-configuration, wherein the N-terminus is optionally modified by acetylation, and wherein the C-terminus is optionally modified by amidation and/or methylation.
A method for ameliorating amyotrophic lateral sclerosis (ALS) in a subject suffering from ALS comprising administering to said subject an effective amount of a polypeptide selected from the group consisting of:
A method for ameliorating chronic renal disease, renal disease, and/or end-stage renal disease in a subject suffering therefrom comprising administering to said subject an effective amount of a polypeptide selected from the group consisting of:
Dependencies are inferred from the claim text.